Miyako Kishimoto

Summary

Publications

  1. pmc Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, Tokyo, Japan Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    Diabetes Metab Syndr Obes 6:187-95. 2013
  2. pmc Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, and Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Diabetes Ther 3:11. 2012
  3. pmc A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, Diabetes and Metabolism Information Center, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Cardiovasc Diabetol 10:115. 2011
  4. ncbi request reprint A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections
    Masahide Okamoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, National Center for Global Health and Medicine, Tokyo 162 8655, Japan
    Endocr J 60:951-7. 2013
  5. ncbi request reprint Successful treatment of chronic intractable itching using oral pregabalin in a patient with diabetes and systemic prurigo nodularis: a case report of an iliopsoas muscle abscess
    Kenjiro Imai
    Department of Diabetes and Metabolic Medicine, Center Hospital, National Center for Global Health and Medicine, Japan
    Intern Med 52:2629-33. 2013
  6. ncbi request reprint A newer conversion equation for the correlation between HbA1c and glycated albumin
    Kaori Inoue
    Department of Endocrinology, Diabetes, and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo 162 8655, Japan
    Endocr J 61:553-60. 2014
  7. pmc Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study
    Tetsuro Tsujimoto
    Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    BMJ Open 1:e000139. 2011
  8. doi request reprint Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy
    Daisuke Takarabe
    Department of Diabetes and Metabolic Medicine, AIDS Clinical Center, National Center for Global Health and Medicine, Toyama 1 21 1, Shinjuku ku, Tokyo 162 8655, Japan
    J Clin Endocrinol Metab 95:4056-60. 2010
  9. ncbi request reprint Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo, Japan
    J Med Invest 58:86-94. 2011
  10. ncbi request reprint A morbid obese Japanese woman with a body mass index of 83.2 kg/m2: before and after sleeve gastrectomy
    Maki Goto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Japan
    Intern Med 51:969-75. 2012

Collaborators

Detail Information

Publications14

  1. pmc Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, Tokyo, Japan Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    Diabetes Metab Syndr Obes 6:187-95. 2013
    ..However, continued evaluation in long-term studies and clinical trials is required to evaluate the efficacy and safety of the drug as well as to identify additional indications for its clinical use...
  2. pmc Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, and Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Diabetes Ther 3:11. 2012
    ..To examine the efficacy of sitagliptin and miglitol when added to ongoing insulin treatment in a patient with type 2 diabetes who had undergone partial gastrectomy...
  3. pmc A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, Diabetes and Metabolism Information Center, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Cardiovasc Diabetol 10:115. 2011
    ..Therefore, glycemic control with the combination of these drugs is warranted...
  4. ncbi request reprint A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections
    Masahide Okamoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, National Center for Global Health and Medicine, Tokyo 162 8655, Japan
    Endocr J 60:951-7. 2013
    ..The findings of the present study showed that octreotide LAR could be useful for the long-term treatment of unresectable insulinomas. ..
  5. ncbi request reprint Successful treatment of chronic intractable itching using oral pregabalin in a patient with diabetes and systemic prurigo nodularis: a case report of an iliopsoas muscle abscess
    Kenjiro Imai
    Department of Diabetes and Metabolic Medicine, Center Hospital, National Center for Global Health and Medicine, Japan
    Intern Med 52:2629-33. 2013
    ..Pregabalin significantly improved the patient's pruritus and decreased the risk of infection. ..
  6. ncbi request reprint A newer conversion equation for the correlation between HbA1c and glycated albumin
    Kaori Inoue
    Department of Endocrinology, Diabetes, and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo 162 8655, Japan
    Endocr J 61:553-60. 2014
    ..Based on all the data points, the resulting equation was HbA1c = 0.216 × GA + 2.978 [R(2) = 0.5882, P < 0.001]. ..
  7. pmc Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study
    Tetsuro Tsujimoto
    Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    BMJ Open 1:e000139. 2011
    ..18; 95% CI 2.30 to 16.64; p<0.001). Conclusions Asymptomatic CHD with ≥50% diameter stenosis and myocardial perfusion abnormalities was detected in more than half of the patients with type 2 diabetes with vascular complications...
  8. doi request reprint Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy
    Daisuke Takarabe
    Department of Diabetes and Metabolic Medicine, AIDS Clinical Center, National Center for Global Health and Medicine, Toyama 1 21 1, Shinjuku ku, Tokyo 162 8655, Japan
    J Clin Endocrinol Metab 95:4056-60. 2010
    ..However, no reports have described the development of autoimmune diabetes during HAART...
  9. ncbi request reprint Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo, Japan
    J Med Invest 58:86-94. 2011
    ..However, we may interpret this result as suggesting that ezetimibe can be used in any population to lower low-density lipoprotein cholesterol levels...
  10. ncbi request reprint A morbid obese Japanese woman with a body mass index of 83.2 kg/m2: before and after sleeve gastrectomy
    Maki Goto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Japan
    Intern Med 51:969-75. 2012
    ..We followed the clinical changes before and after the operation. This case provides potentially interesting information regarding operative treatment for morbid obesity in Japanese...
  11. doi request reprint A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a Brenner tumor
    Tetsuro Tsujimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Japan
    Am J Med Sci 341:74-7. 2011
    ..This case is extremely rare, but the case was accurately diagnosed through a comprehensive analysis...
  12. ncbi request reprint Immunohistochemical findings in the pancreatic islets of a patient with transfusional iron overload and diabetes: case report
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo, Japan
    J Med Invest 57:345-9. 2010
    ....
  13. pmc The Great East Japan Earthquake: Experiences and Suggestions for Survivors with Diabetes (perspective)
    Miyako Kishimoto
    Chief, Department of Diabetes and Metabolic Medicine, Center Hospital, and Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    PLoS Curr 4:e4facf9d99b997. 2012
    ..We also recommend the creation of basic guidelines to facilitate the practical prescription of medication for diabetic patients under various conditions that may arise in the aftermath of a natural disaster...
  14. ncbi request reprint Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients
    Atsushi Goto
    Department of Diabetes and Metabolic Medicine, International Medical Center of Japan, Toyama Hospital, Tokyo, Japan
    Endocr J 57:237-44. 2010
    ..In conclusion, this study suggests that BMI, FPG, sCPR, and uCPR are strong predictors of the future insulin use in type 2 diabetic patients...